PUBLIC CONTRACT · 2024
6100002/2024 - Ustecinumab biossimilar nas dosagens de 90 mg e 130 mg
- Contract value
- €41,800.00
- Signed on
- 11 December 2024
- Procedure
- Prior consultation (Consulta Prévia)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 11286831PUBLISHED SUBJECT
6100002/2024 - USTECINUMAB BIOSSIMILAR NAS DOSAGENS DE 90 MG e 130 MG
Parties involved
- Place of performance
- Portugal, Setúbal, Barreiro
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- CELLTRION PORTUGAL, UNIPESSOAL LDA · Tax ID 518028135
- Bidder
- AMGEN BIOFARMACÊUTICA, LDA. · Tax ID 502942959
- Bidder
- SANDOZ FARMACÊUTICA, LDA. · Tax ID 506985261
Values and timeline
- Contract price
- €41,800.00
- Procedure base price
- €52,000.00
- Total effective price
- €41,800.00
- Publication date
- 17 March 2025
- Award date
- 11 December 2024
- Signing date
- 11 December 2024
- Performance period
- 61 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Prior consultation (Consulta Prévia)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 20.º, n.º 1, alínea c) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 7517192
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.